• sense clinically
  • think mechanistically
  • act interdisciplinarily
  • treat innovatively

Prof. Dr. med. Lars Bullinger

Director of the Medical Department
Division of Hematology, Oncology, and Tumor Immunology
Charité - Universitätsmedizin Berlin
Augustenburger Platz 1
13353 Berlin
Tel: +49 30 450 553 111
Fax: +49 30 450 553 914

https://haema-onko-cvk.charite.de/forschung/arbeitsgruppen/ag_bullinger/

Selected References

  • Hirsch, S., Blätte, T. J., Grasedieck, S., Cocciardi, S., Rouhi, A., Jongen-Lavrencic, M., … Bullinger, L. (2017). Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia. Haematologica, 102(12), 2039–2047. doi:10.3324/haematol.2017.172866
  • Blätte, T. J., Schmalbrock, L. K., Skambraks, S., Lux, S., Cocciardi, S., Dolnik, A., … Bullinger, L. (2019). getITD for FLT3-ITD-based MRD monitoring in AML. Leukemia. doi:10.1038/s41375-019-0483-z
  • Cocciardi, S., Dolnik, A., Kapp-Schwoerer, S., Rücker, F. G., Lux, S., Blätte, T. J., … Döhner, K. (2019). Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation. Nature Communications, 10(1). doi:10.1038/s41467-019-09745-2
  • Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., … Campbell, P. J. (2016). Genomic Classification and Prognosis in Acute Myeloid Leukemia. New England Journal of Medicine, 374(23), 2209–2221. doi:10.1056/nejmoa1516192